Coproporphyrinogen oxidase (CPO) (EC 1.3.3.3), the antepenultimate enzyme in the heme biosynthetic pathway, catalyzes the conversion of coproporphyrinogen III to protoporphyrinogen IX. Previously, based upon metal analysis and site-directed mutagenesis of purified recombinant enzyme, it has been suggested that CPO contains and requires copper for activity (Kohno, H., Furukawa, T., Tokunaga, R., Taketani, S., and Yoshinaga, T. (1996) Biochim. Biophys. Acta 1292, 156 -162). To examine this putative metal site in human CPO, the cDNA encoding human CPO was engineered into an expression vector with a His 6 tag at its amino terminus, and the protein was expressed in Escherichia coli and purified to apparent homogeneity using nickel-nitroliotriacetic acid resin. Activity of the purified protein was monitored by a coupled fluorometric assay that employed purified protoporphyrinogen oxidase to convert protoporphyrinogen to protoporphyrin, thereby allowing the direct fluorescent determination of protoporphyrin IX produced. CPO has an apparent K m of 0.6 M and an apparent K cat of 16 min ؊1 with coproporphyrinogen III as substrate. Metal analysis of the enzyme was carried out via ultraviolet and visible spectroscopy, inductively coupled plasma atomic emission spectroscopy metal analysis, and electron paramagnetic resonance spectroscopy. The data presented demonstrate that human CPO contains no metal center, that it is not stimulated in vitro by iron or copper, and that addition of these metals to cultures expressing the protein has no effect.Coproporphyrinogen oxidase (CPO) 1 (EC 1.3.3.3) catalyzes the antepenultimate step in the heme biosynthetic pathway, the oxidative decarboxylation of coproporphyrinogen III to protoporphyrinogen IX. In this reaction two molecules of O 2 are consumed, and two molecules CO 2 and two protons are released in the conversion of the 2-and 4-propinyl groups to vinyl groups (1). CPO has been cloned and its DNA sequence has been determined for a number of prokaryotic and eukaryotic organisms including, yeast (2), soybean (3), Salmonella typhimurium (4), Escherichia coli (5), mouse (6), and human (7,8). The enzyme has been purified from several sources including bovine liver (9), mouse liver (10), yeast (11), and mouse (recombinant) (12). The enzyme is believed to be located in the intermembrane space of the mitochondria associated with the outer surface of the inner membrane (13).Deficiency in this enzyme in humans leads to hereditary coproporphyria (HCP). This disorder is an autosomal dominant disease. In most cases of HCP, CPO activity is reduced to approximately 50%, which leads to excretion of coproporphyrin in urine and stool. Symptoms of the disease include neurological disturbances and cutaneous photosensitivity (14). Recent sequencing of the human CPO gene has allowed the identification of mutations leading to HCP. From the primary sequence of the protein, these mutations appear to be diverse. Two such mutations are a glycine to serine near the NH 2 terminus (15) and an arginine to trypt...